This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Photo by Cedars-Sinai milla1cf Fri, 03/01/2024 - 08:25 March 1, 2024 — Two new studies by Cedars-Sinai investigators support using artificial intelligence (AI) to predict sudden cardiac arrest-a health emergency that in 90% of cases leads to death within minutes. Sumeet Chugh, MD.
Pocket-Sized Kardia 12L ECG System milla1cf Tue, 06/25/2024 - 18:55 June 25, 2024 — AliveCor , the global leader in AI -powered cardiology, today announced the U.S. Food and Drug Administration ( FDA ) clearance and commercial launch of KAI 12L AI technology and the Kardia 12L ECG System.
Getty Images milla1cf Mon, 04/01/2024 - 08:21 April 1, 2024 — Roughly 25,000 Americans die each year from valvular heart disease, but researchers from Rutgers Health and other institutions conclude that new technology could soon help doctors slash that number. “We What is Valvular Heart Disease?
milla1cf Wed, 01/03/2024 - 12:09 January 3, 2024 — iRhythm Technologies, Inc. , With improved clinical accuracy compared to existing traditional Holter monitoring 6,7 , we look forward to introducing our innovative technology to many more patients in Europe.” iRhythm Technologies, 2022. iRhythm Technologies, 2023.
milla1cf Thu, 04/04/2024 - 12:16 April 4, 2024 — Viz.ai , a leader in AI-powered disease detection and intelligent care coordination, announced new clinical data supporting advancements in cardiology care. The Viz HCM module is the first and only AI algorithm cleared by the FDA for HCM. “At sensitivity.
Our AI-powered, portable Kardia 12L is AliveCor's first device developed exclusively for use by healthcare providers, paving the way to bring this clinically-validated ECG technology to patients anytime and anywhere." KAI 12L is the world's first AI to detect 35 cardiac determinations, including heart attacks, using a reduced leadset.
An international consensus statement on how to treat atrial fibrillation with catheter or surgical ablation has been published in EP Europace, a journal of the European Society of Cardiology (ESC), and was recently presented at EHRA 2024, a scientific congress held April 7-9 in Berlin, Germany. Image courtesy: European Society of Cardiology.
milla1cf Fri, 04/12/2024 - 20:53 April 12, 2024 — HeartBeam, Inc. , milla1cf Fri, 04/12/2024 - 20:53 April 12, 2024 — HeartBeam, Inc. , HeartBeam’s core vectorelectrocardiography (3D VECG) technology captures the heart’s signals in three projections (X, Y, Z), similar to VCG, and synthesizes a 12-lead ECG.
Advancements in medical technology have revolutionized the diagnosis and treatment of heart diseases, which pose critical chronic conditions that, if left unattended, can have fatal consequences. Traditional tools like stethoscopes, blood pressure gauges, and electrocardiograms (ECG) are fundamental for standard diagnostic practices.
Image courtesy: VizAI milla1cf Thu, 04/04/2024 - 12:16 April 4, 2024 — Viz.ai , a leader in AI-powered disease detection and intelligent care coordination, announced new clinical data supporting advancements in cardiology care. The Viz HCM module is the first and only AI algorithm cleared by the FDA for HCM. “At sensitivity.
Signify Research has just released a deep-dive qualitative analysis of developments around the use of AI to analyze and interpret electrocardiograms (ECGs), one of the world’s most ubiquitous diagnostic tests for cardiac disease. Expect to see big and possibly unexpected things in this market in 2024 and beyond.
Italy is pioneering a push for telemedicine and home care in cardiology with the application of groundbreaking new regulation that took effect in January 2024. This is radically simplifying the patient pathway for Electrocardiogram (ECG) tests. Conclusion Across Europe, many healthcare systems are facing similar challenges.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content